TCAs, or tricyclic antidepressants, are an older class of medications originally developed in the 1950s to treat depression. They work by increasing levels of two chemical messengers in the brain, serotonin and norepinephrine, which play key roles in mood, attention, and pain perception. While newer antidepressants have largely replaced them as first-line treatments for depression, TCAs remain widely prescribed for chronic pain, migraines, and several other conditions.
How TCAs Work in the Brain
Your brain cells communicate by releasing chemical messengers called neurotransmitters into the tiny gaps between nerve cells. Normally, after a message is sent, the sending cell reabsorbs those chemicals through a process called reuptake. TCAs block this reuptake for two specific neurotransmitters: serotonin and norepinephrine. The result is that more of these chemicals remain available in the gap between nerve cells, strengthening the signals they carry.
Different TCAs lean toward one neurotransmitter or the other. Some primarily boost serotonin, while others have a stronger effect on norepinephrine. This distinction matters because the same reuptake-blocking action that helps with depression also appears to be what makes TCAs effective for nerve pain and headache prevention. TCAs also interact with several other receptor systems in the body, which explains both their versatility and their tendency to cause side effects.
Common TCA Medications
The FDA has approved several TCAs, most of them for major depressive disorder. The most commonly prescribed include:
- Amitriptyline (Elavil): one of the most widely used, frequently prescribed off-label for chronic pain and migraine prevention
- Nortriptyline (Pamelor): often better tolerated than amitriptyline, also used for nerve pain
- Imipramine (Tofranil): one of the first TCAs developed
- Desipramine (Norpramin): tends to cause fewer sedating effects
- Doxepin (Silenor): also approved for insomnia at low doses
- Clomipramine (Anafranil): the only TCA specifically approved for obsessive-compulsive disorder, including in people aged 10 and older
Others include amoxapine, protriptyline, and trimipramine, though these are prescribed less frequently.
What TCAs Are Used For
Depression was the original target, and TCAs can be highly effective for it. But in practice, they’re now prescribed just as often for conditions that have nothing to do with mood. Chronic nerve pain (neuropathic pain), migraine prevention, tension headaches, fibromyalgia, and insomnia are all common reasons a doctor might reach for a TCA. The pain-relieving effects typically kick in at lower doses than those needed for depression.
Clomipramine stands out as the one TCA with a specific FDA approval for OCD. Some TCAs are also used for irritable bowel syndrome, bedwetting in children, and certain anxiety disorders. If you’ve been prescribed a TCA for something other than depression, that’s not unusual. It reflects how broadly these medications affect the nervous system.
Side Effects and Tolerability
The biggest drawback of TCAs compared to newer antidepressants is their side effect profile. Because they don’t just target serotonin and norepinephrine but also block other receptor systems throughout the body, they tend to cause a wider range of unwanted effects.
The most common complaints stem from their anticholinergic activity: dry mouth, constipation, blurry vision, and difficulty urinating. These are frequent enough that they’re a leading reason people stop taking the medication early. Many people also experience drowsiness, weight gain, and dizziness upon standing (from a drop in blood pressure). Some of these effects lessen over the first few weeks as your body adjusts, but others can persist.
By comparison, SSRIs (the newer class of antidepressants that includes medications like fluoxetine and sertraline) don’t cause anticholinergic effects, are less sedating, and don’t typically lower blood pressure. Their most common side effects, such as nausea, headache, and sexual dysfunction, are generally milder. This more favorable safety profile is the main reason SSRIs replaced TCAs as the go-to treatment for depression. Studies consistently show that fewer people discontinue SSRIs due to side effects, and SSRIs don’t impair thinking and memory the way TCAs can.
Overdose Risk and Cardiac Effects
One of the most serious concerns with TCAs is their danger in overdose. Nearly all TCAs are potentially fatal if taken in large quantities, which sets them apart from SSRIs and most other modern antidepressants. This risk is a major factor in prescribing decisions, particularly for patients with suicidal thoughts.
The danger comes largely from their effects on the heart. In overdose, TCAs can disrupt the electrical conduction system that keeps the heart beating in rhythm. This can lead to dangerously abnormal heart rhythms, complete heart block, and cardiac arrest. TCAs also cause low blood pressure and central nervous system depression (extreme sedation, seizures, or coma) at toxic doses. For this reason, prescribers often limit the quantity dispensed at one time and may choose a different medication class entirely for patients considered at higher risk.
Drug Interactions and Metabolism
TCAs are broken down primarily by liver enzymes in the cytochrome P450 system. This matters because many other medications use the same enzymes. If you take a drug that slows down these enzymes, TCA levels in your blood can rise higher than expected, increasing the risk of side effects or toxicity. Conversely, medications that speed up these enzymes can make TCAs less effective.
The liver also converts some TCAs into active byproducts that contribute to both therapeutic effects and side effects. Genetic differences in how efficiently your liver processes these drugs can mean that the same dose produces very different blood levels in different people. This is one reason doctors sometimes order blood tests to check TCA levels, especially if you’re not responding as expected or experiencing unusual side effects.
How TCAs Compare to SSRIs
For straightforward depression, SSRIs are generally tried first. They work about as well as TCAs for most people but are safer and easier to tolerate. SSRIs don’t carry the same overdose risk, don’t cause the dry mouth and constipation that make TCAs uncomfortable, and don’t affect heart rhythm in the same way.
TCAs still have a role, though. They can be effective when SSRIs haven’t worked, and for certain conditions like nerve pain and migraine prevention, they remain a front-line option. Some people simply respond better to TCAs than to newer medications. The choice between the two classes comes down to the specific condition being treated, the person’s other health issues, and how they’ve responded to medications in the past.
Starting and Adjusting Treatment
TCAs are typically started at a low dose and increased gradually. For nortriptyline, a common starting point is 25 mg taken three to four times daily, with a maximum of 150 mg per day. Older adults and teenagers usually start lower, around 30 to 50 mg per day. Other TCAs follow a similar pattern of gradual dose increases over several weeks.
It often takes two to four weeks before the mood-related benefits become noticeable, though side effects like drowsiness may appear right away. Pain relief sometimes begins sooner and at lower doses than those used for depression. If you’re prescribed a TCA, expect your provider to start conservatively and adjust based on how you respond, both in terms of benefit and side effects.